[Staged oncological screening with TG test]

Area of Science:

• Oncology
• Diagnostic Medicine
• Public Health

Context:

• Current cancer screening methods often face challenges in population coverage and cost-effectiveness.
• Early detection of cancer is crucial for improving patient outcomes and reducing treatment burdens.
• Identifying high-risk individuals requires efficient and accessible diagnostic tools.

Purpose:

• To analyze existing screening methods for early cancer diagnostics and high-risk individual detection.
• To propose a structured, step-by-step screening program to enhance population coverage and reduce reliance on specialized diagnostic tests.
• To evaluate the efficacy and cost-effectiveness of the TG-test as a universal indicator for blastomatous processes.

Summary:

• The authors analyzed various cancer screening strategies, proposing a phased approach to broaden prophylactic examinations and minimize the need for specialized tests.
• The TG-test is highlighted as a highly informative indicator for detecting neoplastic processes at all stages, including preclinical.
• Implementation of this screening program demonstrated a doubled rate of oncopathology detection and a threefold reduction in diagnostic costs compared to standard methods.

Impact:

• The proposed screening program significantly increases the detection rate of cancer, with one-third of tumors diagnosed at the preclinical stage.
• This approach enhances the medical efficiency of oncological screening, leading to earlier interventions and potentially better prognoses.
• The cost-effectiveness of the screening program offers a scalable solution for widespread cancer detection and prevention initiatives.